Rosen Comments on Prospects for COVID-19 Vaccine This Year
30 July 2020
Memphis Business Journal
Partner David Rosen was quoted in a Memphis Business Journal article, “A COVID-19 vaccine this year? It’s a long shot, but it’s possible,” about drug companies considering the use of a little-known regulatory tool to push their COVID-19 vaccines into Americans’ hands before the end of the year.
Rosen, who chairs the firm’s FDA regulatory practice, said the government’s decision to enact the Public Readiness and Emergency Preparedness (PREP) Act in response to the COVID-19 outbreak limits the legal repercussions that drugmakers could face if their COVID-19 products cause physical injury, death and other ill effects to users.
(Subscription required.)
People
Related News
20 September 2024
In the News
David Rosen Featured for Insight on Looming FDA Final Rule for Cosmetic Manufacturing
Foley & Lardner LLP partner David Rosen is featured by CosmeticsDesign for his insights on the U.S. Food and Drug Administration's final rule establishing Good Manufacturing Practices for the cosmetics industry in the article, "Preparing for MoCRA’s 2025 cGMP deadline: What cosmetic manufacturers and suppliers need to know."
19 September 2024
In the News
Patrick Daugherty on UChicago's Desk Reference for Crypto, Web3 – 'This is very much for lawyers'
Foley & Lardner LLP partner Patrick Daugherty commented on the University of Chicago Law School's recently released open-access legal desk reference on crypto and Web3 matters in the Law.com article, "UChicago Law Professors Release Desk Reference Breaking Down Crypto, Web 3 for Attorneys."
18 September 2024
In the News
Eli Mazour Talks Patents on IPWatchdog Unleashed Podcast
Foley & Lardner of counsel Eli Mazour appeared on the IPWatchdog Unleashed podcast episode, "Problems, Solutions and the Case for Patents," to discuss patents and innovation, the Federal Circuit, the value of patents to clients, and patent strategy.